Vicore Pharma Holding AB (publ)
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VICO.ST research report →
Companywww.vicorepharma.com
Vicore Pharma Holding AB (publ) engages in the research and development of pharmaceutical products for the treatments for rare lung diseases. The company is developing VP01, a small molecule compound for oral administration that is in phase II clinical trial for the treatment of interstitial lung diseases, idiopathic pulmonary fibrosis (IPF), systemic sclerosis, and COVID-19; and VP02, a formulation and delivery route for an existing immunomodulatory compound, which is preclinical trials to treat patients with IPF. It has a cooperation and development agreement with Emeriti Bio AB; license agreement with Nanologica AB (publ); and a collaboration agreement with Alex Therapeutics AB for the development and clinical validation of a digital therapeutic (DTx) built on the Alex DTx platform.
- CEO
- Ahmed S. Mousa
- IPO
- 2015
- Employees
- 33
- HQ
- Stockholm, SE
Price Chart
Valuation
- Market Cap
- $2.60B
- P/E
- -6.47
- P/S
- 737.26
- P/B
- 3.10
- EV/EBITDA
- -4.51
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 78.45%
- Op Margin
- -13790.90%
- Net Margin
- -13454.92%
- ROE
- -50.04%
- ROIC
- -48.99%
Growth & Income
- Revenue
- $3.82M · -96.51%
- Net Income
- $-477,474,000 · -183.14%
- EPS
- $-1.99 · -165.33%
- Op Income
- $-454,445,000
- FCF YoY
- 100.00%
Performance & Tape
- 52W High
- $14.10
- 52W Low
- $7.35
- 50D MA
- $10.26
- 200D MA
- $10.80
- Beta
- -0.08
- Avg Volume
- 548.67K
Get TickerSpark's AI analysis on VICO.ST
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our VICO.ST Coverage
We haven't published any research on VICO.ST yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate VICO.ST Report →